2[3]Broadus AE, Mangin M, Ideda K et al. Humoral hypercalcaemia of cancer: identification of a novel parathyroid hormone- like peptide. N Engl J Med, 1988,319:556～563
3[4]Johnson RA, Boyce BF, Mundy GR, et al. Tumours producing human tumor necrosis factor induce hypercalcaemia and osteoclastic bone resorption in nude mice,Endocrinology, 1989,124: 1424～ 1427
4[5]Garett IR. Dure BGM. Nedwin GE, et al. Production of lymphotoxin, a bone - resorbing cytokine, by cultured human myeloma cells. N Engl J Med, 1987,317 : 526～ 532
5[6]Jung A. Bornand J. Mermillod B, et al. In hibition by diphosphonates of bone resorption induced by the walker tumor of the rat. Cancer Res, 1984,44:3007～3011
6[7]Fleish H. Diphosphonates mechanisms of action and clinical applications. In: Peck WA, ed. Bone and Mineral Research.Excerpta Medica, Amsterdam - Oxford - Princeton, 1983,319～357
7[8]Delmas PD, Charhon S, Chapuy MC, et al, Long - term effect of dichloromethylene diphosphonate (Cl2MDP)on skeletal lesions in multiple myeloma. Metab Bone Dis Res 1982,4: 163～168
8[9]Monkkonen JA. One year follow up study of the distribution of 14C - clodronate in mice and rats. Pharmacol Toxicol,1987,89:287～292
9[10]Kanis JA, Preston CJ, Yates AJP, et al. Effects of intravenous diphosphonates on renal function. Lancet,1983,1:1328
10[11]Mithal NP. Retreatment with radiotherapy for painful bone metastates. Int J Radiat Oncol Bio Phys, 1994,29 (5): 1011
